Related Experiment Video
Updated: Jan 27, 2026
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
[The Cardiorenal Syndrome]
Insights
Chronic cardiorenal syndrome, a condition where heart and kidney disease coexist, presents a high risk for cardiovascular events. Management focuses on fluid control and renin-angiotensin-aldosterone system inhibition, improving long-term outcomes.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Chronic cardiorenal syndrome involves the dangerous coexistence of chronic heart disease and chronic kidney disease.
- This condition significantly elevates the risk of cardiovascular events and mortality in affected patients.
- Evidence-based treatment recommendations for this complex syndrome are currently limited.
Purpose of the Study:
- To review the current understanding and management strategies for chronic cardiorenal syndrome.
- To highlight the importance of interdisciplinary care in optimizing patient outcomes.
- To discuss the role of specific pharmacotherapies in managing fluid balance and organ function.
Main Methods:
- Review of existing literature on cardiorenal syndrome.
- Analysis of therapeutic approaches focusing on fluid metabolism and organ stabilization.
- Discussion of the impact of renin-angiotensin-aldosterone system inhibitors and diuretics.
Main Results:
- Fluid metabolism control and stabilization of renal and cardiac function are key therapeutic goals.
- Inhibition of the renin-angiotensin-aldosterone system (RAAS) and diuretics, despite potential short-term renal function decrease (pseudo-worsening), are associated with long-term outcome improvement.
- Interdisciplinary collaboration between nephrologists and cardiologists is crucial.
Conclusions:
- Effective management of chronic cardiorenal syndrome requires a coordinated, interdisciplinary approach.
- Pharmacological interventions targeting the RAAS and fluid balance are essential for improving long-term prognosis.
- Optimizing patient care necessitates minimizing treatment-related side effects while maximizing therapeutic benefits.
Abstract:
In patients with chronic cardio renal syndrome chronic heart disease coexists with chronic kidney disease and poses the patients to a specifically high risk for cardiovascular events and mortality. Treatment recommendations in this condition with a high level of evidence are sparse. Mainstay of therapy in cardiorenal syndrome is fluid metabolism control and stabilization of renal and cardiac function, which can basically been achieved by substances modifying the renin-angiotensin-aldosterone-system as well as diuretics. Noteworthy, despite inducing short-term decreases in renal function, inhibition of the RAAS and diuretic medication associate with the long-term improvements of outcome (so-called pseudo-worsening of renal function). The chronic cardiorenal syndrome calls for interdisciplinary care by both nephrologists and cardiologists in order to allow high-end patient care with a maximum of beneficial effect and a minimum of treatment-related side effects.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
01:30Acute Coronary Syndrome I: Introduction
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:27Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:26Acute Coronary Syndrome V: Nursing Management
01:26Nephrotic Syndrome II : Assessment and Medical Management